scholarly journals Association of autonomic nervous system functions with immune response and prognosis in acute ischemic stroke patients

2012 ◽  
Vol 34 (4) ◽  
pp. 416-422
Author(s):  
Burhanettin Çiğdem ◽  
Özlem Kayım Yıldız ◽  
Mustafa Zahir Bakıcı ◽  
Suat Topaktaş
2021 ◽  
Vol 11 (3) ◽  
pp. 380
Author(s):  
Warawoot Chuangchai ◽  
Wiraporn Pothisiri ◽  
Phumdecha Chanbenjapipu

Background: Ischemic stroke is one of the major causes of disability and mortality. Its effects on the autonomic nervous system (ANS) through nonlinear heart rate variability (HRV) and pulse transit time (PTT) have not been well explored among Thai patients. Objective: This study aims to demonstrate the association between ANS and ischemic stroke through nonlinear HRV and PTT. Methods: In total, 111 patients were enrolled in the study and their short-term HRV and PTT data were collected. Results: Parasympathetic tone was higher in elderly patients (≥60 years). The elderly patients had a higher SD1 but lower SD2 and SD2/SD1 than the younger patients, and a similar pattern was found in the female patients compared to the male patients. These findings were supported by the results of the Poincaré plots. Older and female patients had circular plots and approximately round plots, respectively. Moreover, the parasympathetic nervous system (PNS) response was moderate and positively associated with SD1 (r = 0.47, p < 0.001) and PTT (r = 0.29, p = 0.002), and negatively associated with SD2 and SD2/SD1 (r = −0.47, p < 0.001), after controlling for age and sex. Conclusions: The PNS response was predominant in older and female patients whereas the sympathetic response was lower than in the younger and male patients, which reflected certain characteristics of ANS response to ischemic stroke. Moreover, nonlinear parameters of SD1, SD2, SD2/SD1, and Poincaré plots including PTT are useful and recommended in investigating ANS, particularly in PNS, among ischemic stroke patients.


2002 ◽  
Vol 81 (10) ◽  
pp. 721-725 ◽  
Author(s):  
L. Muslumanoglu ◽  
G. Akyuz ◽  
S. Aki ◽  
S. Karsidag ◽  
O. Us

2012 ◽  
Vol 97 (11) ◽  
pp. 1186-1202 ◽  
Author(s):  
Marcus Paulo Ribeiro Machado ◽  
Aletheia Moraes Rocha ◽  
Lucas Felipe de Oliveira ◽  
Marília Beatriz de Cuba ◽  
Igor de Oliveira Loss ◽  
...  

Life Sciences ◽  
1990 ◽  
Vol 46 (6) ◽  
pp. 419-425 ◽  
Author(s):  
Gerda Croiset ◽  
Cobi J. Heijnen ◽  
Wim E. van der Wal ◽  
Sietse F. de Boer ◽  
David de Wied

2021 ◽  
Vol 22 (5) ◽  
pp. 2357
Author(s):  
Angelica Carandina ◽  
Giulia Lazzeri ◽  
Davide Villa ◽  
Alessio Di Fonzo ◽  
Sara Bonato ◽  
...  

Ischemic stroke is a worldwide major cause of mortality and disability and has high costs in terms of health-related quality of life and expectancy as well as of social healthcare resources. In recent years, starting from the bidirectional relationship between autonomic nervous system (ANS) dysfunction and acute ischemic stroke (AIS), researchers have identified prognostic factors for risk stratification, prognosis of mid-term outcomes and response to recanalization therapy. In particular, the evaluation of the ANS function through the analysis of heart rate variability (HRV) appears to be a promising non-invasive and reliable tool for the management of patients with AIS. Furthermore, preclinical molecular studies on the pathophysiological mechanisms underlying the onset and progression of stroke damage have shown an extensive overlap with the activity of the vagus nerve. Evidence from the application of vagus nerve stimulation (VNS) on animal models of AIS and on patients with chronic ischemic stroke has highlighted the surprising therapeutic possibilities of neuromodulation. Preclinical molecular studies highlighted that the neuroprotective action of VNS results from anti-inflammatory, antioxidant and antiapoptotic mechanisms mediated by α7 nicotinic acetylcholine receptor. Given the proven safety of non-invasive VNS in the subacute phase, the ease of its use and its possible beneficial effect in hemorrhagic stroke as well, human studies with transcutaneous VNS should be less challenging than protocols that involve invasive VNS and could be the proof of concept that neuromodulation represents the very first therapeutic approach in the ultra-early management of stroke.


Sign in / Sign up

Export Citation Format

Share Document